Home › Idiopathic Pulmonary Fibrosis › Alabama
Idiopathic Pulmonary Fibrosis clinical trials in Alabama
9 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Alabama.
Cities in Alabama
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Birmingham
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- UAB Lung Health Center, Birmingham
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- The University of Alabama at Birmingham /ID# 277613, Birmingham
- Sec Clinical Research - East - Dothan - Graceland /ID# 278328, Dothan
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07230288Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
- The University of Alabama at Birmingham, Birmingham
RecruitingPhase 1
Ages 40 to 85 · All sexes · Updated Aug 12, 2026 · NCT04362644Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Alabama - Birmingham, Birmingham
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Birmingham, AL, Birmingham
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.